Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sex and Genotype Differences in Stress Effects on Executive Functions
NCT04273880Phase 1Recruiting
- Sponsor
- University of British Columbia
- Start
- Apr 2018
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methylphenidate (2 arms), sponsored by University of British Columbia. Primary endpoints: Selective attention as assessed by the Flanker/Reverse Flanker task at 1 Month, Working memory as assessed by the N-back task at 1 Month and 2 more. Started Apr 2018; status: recruiting.
02
Drugs
methylphenidate
Beyond the preview
Go deeper on NCT04273880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273880.